CommercialCoverageMedium impact
06.02.37a, Immune Cell Function Assay
Independence Blue Cross·Allergy & Immunology, Internal Medicine, Infectious Disease +2 more·Medical Policy
Effective date
Jun 24, 2026
We identified it
Jun 25, 2026
Summary
Policy 06.02.37a regarding Immune Cell Function Assay has been reissued effective 06/24/2026. Without access to the full policy text content, specific billing impacts cannot be determined. The billing team must retrieve the complete policy document to identify coverage changes, code updates, or prior authorization requirements.
Action Required
By 06/24/2026: Billing team must access the full policy text at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=06&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#commercial-06-02-37a to review the complete reissued policy. Document any changes to: (1) covered CPT/HCPCS codes for immune cell function testing, (2) prior authorization requirements, (3) medical necessity criteria, and (4) any superseded prior guidance. Update billing system rules, encounter forms, and provider documentation templates accordingly. Communicate changes to billing staff and providers before the effective date to prevent claim denials or processing delays.